CAR-T（CAR-T）细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T（CAR-T）细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
混合嵌合抗原受体（CAR）γδ T 细胞用于口腔癌治疗：增强安全性和靶向疗效
英文原题：Hybrid Chimeric Antigen Receptor (CAR) γδ T Cells for Oral Cancer Therapy: Enhanced Safety and Targeted Efficacy.
查看英文原题
Hybrid Chimeric Antigen Receptor (CAR) γδ T Cells for Oral Cancer Therapy: Enhanced Safety and Targeted Efficacy.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
摘要
这条来源本身就没有摘要（PubMed 未提供），不是「还没翻译」。可以点最下面的「在 PubMed 查看」打开原文献页面。
论文信息
- 作者
- Kamala K、Sivaperumal P
- 第一作者单位
- Marine Microbial Research Lab, Department of Research and Analytics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu 600 077, India; Centre for Marine and Aquatic Research (CMAR), Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu 602105, India.India
- 通讯作者单位
- Marine Biomedical Research Lab & Environmental Toxicology Unit, Cellular and Molecular Research Centre, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu 600 077, India; Centre for Marine and Aquatic Research (CMAR), Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu 602105, India.India
- 文献类型
- 读者来信
- 期刊
- Clinical oncology (Royal College of Radiologists (Great Britain))2025 Jan
- 原文标识
- PubMed 39577200 · DOI 10.1016/j.clon.2024.103683